Joel L. Moake

14.1k citations

146 papers · 10.4k indexed · 4 hit papers · h-index 49

Impact in

Hematology top 0.05%
- Platelet Disorders and Treatments
- Blood groups and transfusion
- Blood Coagulation and Thrombosis Mechanisms
Nephrology top 0.1%
- Renal Diseases and Glomerulopathies

Papers in

Hematology 107
- Platelet Disorders and Treatments 89
- Blood groups and transfusion 38
- Blood Coagulation and Thrombosis Mechanisms 15
Immunology 82
- Complement system in diseases 82

Co-authors: Leticia Nolasco Nancy A. Turner Larry V. McIntire Jing-fei Dong John Byrnes Christine K. Rudy NA Turner Joseph H. Troll
Journals: Blood (15 papers)American Journal of Hematology (11 papers)Journal of Thrombosis and Haemostasis (10 papers)Thrombosis Research (6 papers)Journal of Clinical Investigation (5 papers)
Partner nations: United States Germany Switzerland

In The Last Decade

Joel L. Moake

144 papers receiving 10.0k citations

Hit Papers

align trajectories log scale

ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions 2002 · 666 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2002 Blood
2002 New England Journal of Medicine
1986 Journal of Clinical Investigation
1982 New England Journal of Medicine

Peers

Countries citing papers authored by Joel L. Moake

Since Specialization

Citations

This map shows the geographic impact of Joel L. Moake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel L. Moake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel L. Moake more than expected).

Fields of papers citing papers by Joel L. Moake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel L. Moake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel L. Moake. The network helps show where Joel L. Moake may publish in the future.

Co-authors

The 25 scholars most cited alongside Joel L. Moake, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joel L. Moake Line = papers co-authored together Joel L. Moake links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Heat-inactivated Factor B inhibits alternative pathway fluid-phase activation and convertase formation on endothelial cell-secreted ultra-large von Willebrand factor strings Scientific Reports ·Nancy A. Turner, Joel L. Moake	2023	1
2	Laminin Peptide-Immobilized Hydrogels Modulate Valve Endothelial Cell Hemostatic Regulation PLoS ONE ·Jiang Zhoul, Allison Post, Adam Yuh Lin, Hubert Tseng, Joel L. Moake, K. Jane Grande‐Allen	2015	22
3	Treatment of refractory thrombotic thrombocytopenic purpura with N ‐acetylcysteine: a case report Transfusion ·A. Solomatin, Hongliang Li, X.Y. Zhang, 诚祝, Joel L. Moake, Mark M. Udden, Martha P. Mims	2013	43
4	Assembly and Activation of Alternative Complement Components on Endothelial Cell-Anchored Ultra-Large Von Willebrand Factor Links Complement and Hemostasis-Thrombosis PLoS ONE ·Nancy A. Turner, Joel L. Moake	2013	95
5	Thrombotic Microangiopathies: Multimers, Metalloprotease, and Beyond Clinical and Translational Science ·Joel L. Moake	2009	21
6	Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989–2008) Kidney International ·Anaadriana Zakarija, Hau C. Kwaan, Joel L. Moake, Nicholas Bandarenko, Dilip K. Pandey, June M. McKoy, Paul R. Yarnold, Dennis W. Raisch, Jeffrey L. Winters, Thomas J. Raife, John Cursio, Thanh Ha Luu, Elizabeth Richey, Matthew J. Fisher, Thomas L. Ortel, Martin S. Tallman, X. Long Zheng, Masanori Matsumoto, Yoshihiro Fujimura, Charles L. Bennett	2009	60
7	Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group Haematologica ·Tapani Ruutu, Giovanni Barosi, Richard J. Benjamin, Richard E. Clark, James N. George, Aloïs Gratwohl, Ernst Holler, Massimo Iacobelli, Karim Kentouche, Bernhard Lämmle, Joel L. Moake, PG Richardson, Gèrard Socié, Zella R. Zeigler, Dietger Niederwieser, Tiziano Barbui, (unknown)	2007	266
8	Human endothelial cells synthesize and release ADAMTS-13 Journal of Thrombosis and Haemostasis ·NA Turner, Leticia Nolasco, Zhenyin Tao, Jing Dong, Joel L. Moake	2006	140
9	Platelet-derived VWF-cleaving metalloprotease ADAMTS-13 Journal of Thrombosis and Haemostasis ·E. V. Plekhanova, Béatrice Dumiche, Luis Granados, Angela L. Bergeron, Leticia Nolasco, Changgeng Ruan, Joel L. Moake, Oriane Magela Neto	2005	83
10	Recombinant CUB-1 domain polypeptide inhibits the cleavage of ULVWF strings by ADAMTS13 under flow conditions Blood ·Zhenyin Tao, Yuandong Peng, Leticia Nolasco, Santiago Cal, Carlos López-Otı́n, Renhao Li, Joel L. Moake, José A. López, Jing-fei Dong	2005	82
11	Platelets adhered to endothelial cell-bound ultra-large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress Journal of Thrombosis and Haemostasis ·Luis Granados, Chalmette Ball, Leticia Nolasco, Béatrice Dumiche, Joel L. Moake, Oriane Magela Neto	2005	129
12	Measurement of von Willebrand factor cleaving protease (ADAMTS‐13): results of an international collaborative study involving 11 methods testing the same set of coded plasmas Journal of Thrombosis and Haemostasis ·Armando Tripodi, Veena Chantarangkul, Martina Böhm, Ulrich Budde, Jing‐fei Dong, Kenneth D. Friedman, Miriam Galbusera, Jordi Rossinyol Fuentes, Joel L. Moake, Margaret E. Rick, Jan–Dirk Studt, Peter L. Turecek, Pier Mannuccio Mannucci	2004	64
13	A novel flow cytometric analysis for platelet activation on immobilized von Willebrand factor or fibrillar collagen Journal of Thrombosis and Haemostasis ·Shih‐Chieh Kao, NA Turner, Joel L. Moake, Larry V. McIntire	2003	5
14	Thrombotic Thrombocytopenic Purpura Today Hospital Practice ·Joel L. Moake	1999	7
15	Acute renal failure in a female adolescent with leukemia in remission The Journal of Pediatrics ·Roberta A. Gottlieb, Donald Pinkel, Guillaume Tallier, Regina Verani, Shai Ashkenazi, Farzin Eftekhari, Joel L. Moake, Ronald J. Portman	1991	1
16	Granulocyte proteases do not process endothelial cell‐derived unusually large von willebrand factor multimers to plasma vWF in vivo American Journal of Hematology ·Martin D. Phillips, Carlo Del Piano, Leticia Nolasco, Joel L. Moake	1991	7
17	von Willebrand factor binding to platelet GpIb initiates signals for platelet activation. Journal of Clinical Investigation ·Michael H. Kroll, T. Harris, Joel L. Moake, RI Handin, A I Schafer	1991	227
18	Von Willebrand Factor in Thrombotic Thrombocytopenic Purpura and the Hemolytic-Uremic Syndrome Transfusion Medicine Reviews ·Joel L. Moake, César Tomás Laguia	1990	12
19	Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura American Journal of Hematology ·John Byrnes, Joel L. Moake, Panpit Klug, Phillip Periman	1990	105
20	Thrombosis following desmopressin for uremic bleeding American Journal of Hematology ·John Byrnes, Jamiédson José da Silva, Joel L. Moake	1988	81

About Joel L. Moake

Joel L. Moake is a scholar working on Hematology, Immunology, Nephrology, Genetics and Transplantation, having authored 146 papers that have together received 10.4k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (89 papers), Complement system in diseases (82 papers), Blood groups and transfusion (38 papers), Renal Diseases and Glomerulopathies (24 papers), Hemoglobinopathies and Related Disorders (19 papers), Blood Coagulation and Thrombosis Mechanisms (15 papers), Antiplatelet Therapy and Cardiovascular Diseases (13 papers) and Blood properties and coagulation (12 papers). The work is most often cited by research in Hematology (5.9k citations), Nephrology (2.5k citations), Immunology (5.9k citations), Transplantation (573 citations) and Genetics (1.9k citations). Joel L. Moake has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Leticia Nolasco, Nancy A. Turner, Larry V. McIntire, Jing-fei Dong, John Byrnes, Christine K. Rudy, NA Turner, Joseph H. Troll, J. D. Hellums and Suchen L. Hong. Their work appears in journals such as Blood, American Journal of Hematology, Journal of Thrombosis and Haemostasis, Thrombosis Research and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact